A detailed history of Qube Research & Technologies LTD transactions in Lifevantage Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 14,262 shares of LFVN stock, worth $236,891. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,262
Previous 1 1426100.0%
Holding current value
$236,891
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.51 - $13.01 $78,578 - $185,535
14,261 Added 1426100.0%
14,262 $172,000
Q2 2024

Aug 14, 2024

SELL
$5.75 - $7.95 $2,225 - $3,076
-387 Reduced 99.74%
1 $0
Q1 2024

May 14, 2024

SELL
$5.31 - $7.01 $1,885 - $2,488
-355 Reduced 47.78%
388 $2,000
Q4 2023

Feb 13, 2024

BUY
$4.38 - $8.25 $3,249 - $6,121
742 Added 74200.0%
743 $4,000
Q3 2023

Nov 13, 2023

BUY
$4.22 - $7.51 $4 - $7
1 New
1 $0

Others Institutions Holding LFVN

About Lifevantage Corp


  • Ticker LFVN
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Packaged Foods
  • Shares Outstandng 12,560,000
  • Market Cap $209M
  • Description
  • LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...
More about LFVN
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.